The [Ru(bpy)2(CO)2]2+/[Ru(bpy)3]2+ (or [Ru(phen)3]2+)/triethanolamine/N,N-dimethylformamide system reduces CO2 to afford HCOO− efficiently under the irradiation of light (λ>320 nm), where each of the former three components functions as a catalyst, a photosensitizer, and an electron donor, respectively.
No takes yet. Share an insight, caveat, or question.
Ishida et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: